influenza.jpg

LATEST NEWS

For all media inquiries, please contact Olipriya Das.

Oct 8, 2021

Blue Water Vaccines, Inc. Files Registration Statement for Initial Public Offering of Common Stock

Sep 22, 2021

Blue Water Vaccines, Inc. Announces Exclusive Rights to Patent Awarded to Oxford University Innovation Limited for the Development of a Universal Influenza Vaccine

- Blue Water Vaccines' licensing agreement with Oxford University Innovation Limited grants rights to technology developed by Oxford scientists

- Blue Water Vaccines will pay milestone payments to Oxford University Innovation Limited and royalties on sales subject to the achievement of key events

Aug 11, 2021

Blue Water Vaccines Announces the Appointment of Ronald R. Cobb as the Head of Science and Discovery

Jul 13, 2021

Blue Water Vaccines Announces Exclusive, Global License Agreement of Novel Versatile Vaccine Platform from Cincinnati Children's Hospital Medical Center

Jun 17, 2021

Blue Water Vaccines Announces the Appointments of Former Congressman Theodore S. Yoho as the Head of Business Development and Manufacturing Expert Andrew D. Skibo as the Global Head of Biologics Operations

Oct 29, 2020

Blue Water Vaccines Announces Development of Vaccine Candidates to Address G4 EA H1N1 Swine Influenza Virus and Streptococcus Pneumoniae

Feb 10, 2020

Blue Water Vaccines Licenses Patent Rights for Streptococcus Pneumoniae Vaccine Development from St. Jude Children's Research Hospital

Aug 7, 2019

Blue Water Vaccines, Developing Universal Flu Vaccine, to Partner With Ology Bioservices Inc.